About the Szent-Györgyi Prize
The Szent-Györgyi Prize for Progress in Cancer Research is named in memory of Dr. Albert Szent-Györgyi, NFCR’s co-founder and 1937 Nobel Laureate for his study of vitamin C and cell respiration. The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.
The annual Prize honors scientists whose seminal discovery or pioneering body of work has contributed to cancer prevention, diagnosis, or treatment and has had a lasting impact on understanding cancer, holding the promise of improving or saving lives of cancer patients.
The Szent-Györgyi Prize serves to stimulate continued investment in the pioneering research that will produce scientific breakthroughs and promote public awareness of the importance of basic cancer research and the need to accelerate the translation of these research discoveries into new cancer treatments. In addition to winning the coveted award itself, prize recipients are given a $30,000 honorarium and attend a gala in their honor.
Our 2024 Winner, Dennis Slamon, M.D., Ph.D., was honored on October 18, 2024, at the National Press Club in Washington, D.C.
Nominations will close on February 28, 2025. Please submit before then to be considered!
Current Winner
Dr. Slamon’s groundbreaking research has helped shape the field of precision medicine for breast cancer patients.
About the Ceremony
Our next ceremony will take place on October 18, 2024 in Washington, DC.
Past Winners
View all previous awardees of the Szent-Gyorgyi Prize for Progress in Cancer Research.
